Agastiya Biotech
Pre-clinicalAgastiya Biotech is a next-generation oncology company leveraging systems biology, immunotherapy, and quantum biophysics to develop breakthrough cancer treatments. Its lead molecule, AB001, is positioned as a first-in-class, tumor-agnostic, orally available therapeutic with the potential to transform cancer care across multiple indications.
About
Agastiya Biotech is a next-generation oncology company leveraging systems biology, immunotherapy, and quantum biophysics to develop breakthrough cancer treatments. Its lead molecule, AB001, is positioned as a first-in-class, tumor-agnostic, orally available therapeutic with the potential to transform cancer care across multiple indications.
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile